<DOC>
	<DOCNO>NCT00314210</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy quetiapine SR compare placebo increase time randomisation anxiety event patient generalise anxiety disorder ( GAD ) . PLEASE NOTE : Seroquel SR Seroquel XR refer formulation . The SR designation change XR consultation FDA .</brief_summary>
	<brief_title>Safety Efficacy Maintenance Study Quetiapine SR Treat GAD Patients .</brief_title>
	<detailed_description />
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Patients male female , 18 65 year age ( inclusive ) , diagnosis GAD accord DSMIV criterion 300.02 assess MINI . Patients suffer depressive symptom , define Montgomery√Ösberg Depression Rating Scale ( MADRS ) total score 17 enrolment visit , exclude participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Generalised Anxiety Disorder</keyword>
</DOC>